Glucose levels during life and neuropathologic findings at autopsy among people never treated for diabetes

Neurobiology of Aging

Volumn 48, Issue , 2016, Pages 72-82

  Crane, Paul K ^a   Walker, Rod L ^b   Sonnen, Joshua ^c   Gibbons, Laura E ^a   Melrose, Rebecca ^d,e   Hassenstab, Jason ^f   Keene, C Dirk ^a   Postupna, Nadia ^a   Montine, Thomas J ^a   Larson, Eric B ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glucose; Hippocampal sclerosis; Lewy bodies; Neuritic plaques; Neurofibrillary tangles; Neuropathology

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN INFARCTION; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HIPPOCAMPAL SCLEROSIS; HUMAN; HUMAN TISSUE; LACUNAR STROKE; LEWY BODY; LOCUS CERULEUS; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; RISK FACTOR; SENILE PLAQUE; SUBSTANTIA NIGRA; AGING; ALZHEIMER DISEASE; CEREBRAL INFARCTION; HIPPOCAMPUS; METABOLISM; MIDDLE AGED; PATHOLOGY; TUBEROUS SCLEROSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AUTOPSY; BLOOD GLUCOSE; CEREBRAL INFARCTION; DEMENTIA; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HIPPOCAMPUS; HUMANS; LEWY BODIES; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; TUBEROUS SCLEROSIS;

EID: 84988005798     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2016.07.021     Document Type: Article

References (52)

1. Abner, E.L., Nelson, P.T., Kryscio, R.J., Schmitt, F.A., Fardo, D.W., Woltjer, R.L., Cairns, N.J., Yu, L., Dodge, H.H., Xiong, C., Masaki, K., Tyas, S.L., Bennett, D.A., Schneider, J.A., Arvanitakis, Z., Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology. Alzheimers Dement 12 (2016), 882–889.
2. American Psychiatric Association. Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders: DSM-iv. fourth ed., 1994, American Psychiatric Association, Washington, DC.
3. Bennett, D.A., De Jager, P.L., Leurgans, S.E., Schneider, J.A., Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles. Neurology 72 (2009), 1495–1503.
4. Braak, E., Griffing, K., Arai, K., Bohl, J., Bratzke, H., Braak, H., Neuropathology of Alzheimer's disease: what is new since A. Alzheimer?. Eur. Arch. Psychiatry Clin. Neurosci. 249 (1999), 14–22.
5. Braak, H., Braak, E., Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl) 82 (1991), 239–259.
6. Breitner, J.C., Haneuse, S.J., Walker, R., Dublin, S., Crane, P.K., Gray, S.L., Larson, E.B., Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology 72 (2009), 1899–1905.
7. Carlin, B.P., Louis, T.A., Bayes and Empirical Bayes Methods for Data Analysis. second ed., 2000, Chapman & Hall/Crc, Boca Raton, FL.
8. Crane, P.K., Walker, R., Hubbard, R.A., Li, G., Nathan, D.M., Zheng, H., Haneuse, S., Craft, S., Montine, T.J., Kahn, S.E., McCormick, W., McCurry, S.M., Bowen, J.D., Larson, E.B., Glucose levels and risk of dementia. N. Engl. J. Med. 369 (2013), 540–548.
9. Dublin, S., Anderson, M.L., Heckbert, S.R., Hubbard, R.A., Sonnen, J.A., Crane, P.K., Montine, T.J., Larson, E.B., Neuropathologic changes associated with atrial fibrillation in a population-based autopsy cohort. J. Gerontol. A Biol. Sci. Med. Sci. 69 (2014), 609–615.
10. Dugger, B.N., Malek-Ahmadi, M., Monsell, S.E., Kukull, W.A., Woodruff, B.K., Reiman, E.M., Beach, T.G., Wilson, J., A cross-sectional analysis of late-life cardiovascular factors and their relation to clinically defined neurodegenerative diseases. Alzheimer Dis. Assoc. Disord 30 (2016), 223–229.
11. Exalto, L.G., van der Flier, W.M., Scheltens, P., Biessels, G.J., Glycemia and levels of cerebrospinal fluid amyloid and tau in patients attending a memory clinic. J. Am. Geriatr. Soc. 58 (2010), 1318–1321.
12. Gorelick, P.B., Scuteri, A., Black, S.E., DeCarli, C., Greenberg, S.M., Iadecola, C., Launer, L.J., Laurent, S., Lopez, O.L., Nyenhuis, D., Petersen, R.C., Schneider, J.A., Tzourio, C., Arnett, D.K., Bennett, D.A., Chui, H.C., Higashida, R.T., Lindquist, R., Nilsson, P.M., Roman, G.C., Sellke, F.W., Seshadri, S., Vascular contributions to cognitive impairment and dementia. Stroke 42 (2011), 2672–2713.
13. Haneuse, S., Schildcrout, J., Crane, P., Sonnen, J., Breitner, J., Larson, E., Adjustment for selection bias in observational studies with application to the analysis of autopsy data. Neuroepidemiology 32 (2009), 229–239.
14. Hyman, B.T., Phelps, C.H., Beach, T.G., Bigio, E.H., Cairns, N.J., Carrillo, M.C., Dickson, D.W., Duyckaerts, C., Frosch, M.P., Masliah, E., Mirra, S.S., Nelson, P.T., Schneider, J.A., Thal, D.R., Thies, B., Trojanowski, J.Q., Vinters, H.V., Montine, T.J., National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. 8 (2012), 1–13.
15. Kalia, L.V., Lang, A.E., Parkinson's disease. Lancet, 2015, 10.1016/S0140-6736(14)61393-3.
16. Kissela, B.M., Khoury, J., Kleindorfer, D., Woo, D., Schneider, A., Alwell, K., Miller, R., Ewing, I., Moomaw, C.J., Szaflarski, J.P., Gebel, J., Shukla, R., Broderick, J.P., Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care 28 (2005), 355–359.
17. Kloppenborg, R.P., van den Berg, E., Kappelle, L.J., Biessels, G.J., Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur. J. Pharmacol. 585 (2008), 97–108.
18. Kukull, W.A., Higdon, R., Bowen, J.D., McCormick, W.C., Teri, L., Schellenberg, G.D., van Belle, G., Jolley, L., Larson, E.B., Dementia and Alzheimer disease incidence: a prospective cohort study. Arch. Neurol. 59 (2002), 1737–1746.
19. Larson, E.B., Wang, L., Bowen, J.D., McCormick, W.C., Teri, L., Crane, P., Kukull, W., Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann. Intern. Med. 144 (2006), 73–81.
20. Leverenz, J.B., Hamilton, R., Tsuang, D.W., Schantz, A., Vavrek, D., Larson, E.B., Kukull, W.A., Lopez, O., Galasko, D., Masliah, E., Kaye, J., Nixon, R., Clark, C., Trojanowski, J., Montine, T.J., Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol. 18 (2008), 220–224.
21. Leverenz, J.B., McKeith, I.G., Dementia with Lewy bodies. Med. Clin. North Am. 86 (2002), 519–535.
22. Li, G., Larson, E.B., Sonnen, J.A., Shofer, J.B., Petrie, E.C., Schantz, A., Peskind, E., Raskind, M., Breitner, J.C., Montine, T.J., Statin therapy is associated with reduced neuropathologic changes of Alzheimer's disease. Neurology 69 (2007), 878–885.
23. Lima, M.M., Targa, A.D., Noseda, A.C., Rodrigues, L.S., Delattre, A.M., dos Santos, F.V., Fortes, M.H., Maturana, M.J., Ferraz, A.C., Does Parkinson's disease and type-2 diabetes mellitus present common pathophysiological mechanisms and treatments?. CNS Neurol. Disord. Drug Targets 13 (2014), 418–428.
24. Liu, J., Gao, B.B., Clermont, A.C., Blair, P., Chilcote, T.J., Sinha, S., Flaumenhaft, R., Feener, E.P., Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein. Nat. Med. 17 (2011), 206–210.
25. Lu, L., Fu, D.L., Li, H.Q., Liu, A.J., Li, J.H., Zheng, G.Q., Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies. PLoS One, 9, 2014, e85781.
26. Matsuzaki, T., Sasaki, K., Tanizaki, Y., Hata, J., Fujimi, K., Matsui, Y., Sekita, A., Suzuki, S.O., Kanba, S., Kiyohara, Y., Iwaki, T., Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology 75 (2010), 764–770.
27. Mattis, S., Dementia Rating Scale. 1988, Psychological Assessment Resources, Odessa, FL.
28. McKhann, G., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 (1984), 939–944.
29. Mirra, S.S., The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary. Neurobiol. Aging 18 (1997), S91–S94.
30. Mirra, S.S., Heyman, A., McKeel, D., Sumi, S.M., Crain, B.J., Brownlee, L.M., Vogel, F.S., Hughes, J.P., van Belle, G., Berg, L., The Consortium to Establish a Registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 (1991), 479–486.
31. Montine, T.J., Phelps, C.H., Beach, T.G., Bigio, E.H., Cairns, N.J., Dickson, D.W., Duyckaerts, C., Frosch, M.P., Masliah, E., Mirra, S.S., Nelson, P.T., Schneider, J.A., Thal, D.R., Trojanowski, J.Q., Vinters, H.V., Hyman, B.T., National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 123 (2012), 1–11.
32. Mooradian, A.D., Central nervous system complications of diabetes mellitus–a perspective from the blood-brain barrier. Brain Res. Brain Res. Rev. 23 (1997), 210–218.
33. Morris, J.C., Heyman, A., Mohs, R.C., Hughes, J.P., van Belle, G., Fillenbaum, G., Mellits, E.D., Clark, C., The Consortium to Establish a Registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39 (1989), 1159–1165.
34. Nathan, D.M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R.J., Translating the A1C assay into estimated average glucose values. Diabetes Care 31 (2008), 1473–1478.
35. Neltner, J.H., Abner, E.L., Baker, S., Schmitt, F.A., Kryscio, R.J., Jicha, G.A., Smith, C.D., Hammack, E., Kukull, W.A., Brenowitz, W.D., Van Eldik, L.J., Nelson, P.T., Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain 137 (2014), 255–267.
36. Postupna, N., Keene, C.D., Crane, P.K., Gonzalez-Cuyar, L.F., Sonnen, J.A., Hewitt, J., Rice, S., Howard, K., Montine, K.S., Larson, E.B., Montine, T.J., Cerebral cortical Abeta42 and PHF-tau in 325 consecutive brain autopsies stratified by diagnosis, location, and APOE. J. Neuropathol. Exp. Neurol. 74 (2015), 100–109.
37. Prasad, S., Sajja, R.K., Naik, P., Cucullo, L., Diabetes mellitus and blood-brain barrier dysfunction: an overview. J. Pharmacovigil, 2, 2014, 125.
38. Reitan, R.M., Wolfson, D., The Halstead-Reitan Neuropsychological Test Battery. 1985, Neuropsychology Press, Tucson.
39. Roberts, R.O., Knopman, D.S., Cha, R.H., Mielke, M.M., Pankratz, V.S., Boeve, B.F., Kantarci, K., Geda, Y.E., Jack, C.R. Jr., Petersen, R.C., Lowe, V.J., Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation. J. Nucl. Med. 55 (2014), 759–764.
40. Saaksjarvi, K., Knekt, P., Mannisto, S., Lyytinen, J., Heliovaara, M., Prospective study on the components of metabolic syndrome and the incidence of Parkinson's disease. Parkinsonism Relat. Disord. 21 (2015), 1148–1155.
41. Saczynski, J.S., Siggurdsson, S., Jonsson, P.V., Eiriksdottir, G., Olafsdottir, E., Kjartansson, O., Harris, T.B., van Buchem, M.A., Gudnason, V., Launer, L.J., Glycemic status and brain injury in older individuals: the age gene/environment susceptibility-Reykjavik study. Diabetes Care 32 (2009), 1608–1613.
42. Sato, N., Morishita, R., Brain alterations and clinical symptoms of dementia in diabetes: abeta/tau-dependent and independent mechanisms. Front. Endocrinol. (Lausanne), 5, 2014, 143.
43. Sonnen, J.A., Larson, E.B., Crane, P.K., Haneuse, S., Li, G., Schellenberg, G.D., Craft, S., Leverenz, J.B., Montine, T.J., Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann. Neurol. 62 (2007), 406–413.
44. Sonnen, J.A., Larson, E.B., Brickell, K., Crane, P.K., Woltjer, R., Montine, T.J., Craft, S., Different patterns of cerebral injury in dementia with or without diabetes. Arch. Neurol. 66 (2009), 315–322.
45. Sonnen, J.A., Larson, E.B., Walker, R.L., Haneuse, S., Crane, P.K., Gray, S.L., Breitner, J.C., Montine, T.J., Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques. Neurology 75 (2010), 1203–1210.
46. Spreen, O., Strauss, E., Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 1991, Oxford UP, NY.
47. Teng, E.L., Hasegawa, K., Homma, A., Imai, Y., Larson, E., Graves, A., Sugimoto, K., Yamaguchi, T., Sasaki, H., Chiu, D, White, L.R., The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int. Psychogeriatr. 6 (1994), 45–58 discussion 62.
48. Vonsattel, J.P., Myers, R.H., Hedley-Whyte, E.T., Ropper, A.H., Bird, E.D., Richardson, E.P. Jr., Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann. Neurol. 30 (1991), 637–649.
49. Wechsler, D., WMS-R: Wechsler Memory Scale - Revised Manual. 1987, Psychological Corporation/HBJ, NY.
50. White, L., Petrovitch, H., Hardman, J., Nelson, J., Davis, D.G., Ross, G.W., Masaki, K., Launer, L., Markesbery, W.R., Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann. N. Y. Acad. Sci. 977 (2002), 9–23.
51. Zarow, C., Sitzer, T.E., Chui, H.C., Understanding hippocampal sclerosis in elderly: epidemiology, characterization, and diagnostic issues. Curr. Neurol. Neurosci. Rep. 8 (2008), 363–370.
52. Zou, G., A modified poisson regression approach to prospective studies with binary data. Am. J. Epidemiol. 159 (2004), 702–706.